论文部分内容阅读
目的:探讨阿奇霉素治疗小儿支原体肺炎的临床疗效。方法:回顾性分析小儿支原体肺炎患儿60例,将60例支原体肺炎患儿随机分为观察组和对照组各30例,2组其基础治疗相同,均给予抗生素,止咳化痰,观察组给予静滴阿奇霉素10mg/kg.d;对照组给予静滴红霉素15~30mg/kg.d;观察2组疗效及不良反应。结果:观察组的发热消失时间;咳嗽消失时间;肺部罗音消失时间均短于对照组,2组差异有统计学意义(P<0.05)。观察组有效率93.3%;对照组有效率80.0%,2组有效率比较差异有统计学意义(P<0.05)。结论:阿奇霉素治疗小儿支原体肺炎快速,高效,方便,临床疗效好,副作用少,值得临床推广使用。
Objective: To investigate the clinical efficacy of azithromycin in the treatment of mycoplasma pneumonia in children. Methods: Sixty children with mycoplasmal pneumonia were retrospectively analyzed. Sixty children with mycoplasmal pneumonia were randomly divided into observation group and control group, with 30 cases in each group. The two groups were given the same basic treatment with antibiotics, cough and phlegm, and observation group Intravenous azithromycin 10mg / kg.d; control group given intravenous erythromycin 15 ~ 30mg / kg.d; observed two groups of curative effects and adverse reactions. Results: The disappearance of fever, the disappearance of cough and the disappearance of pulmonary rales in the observation group were significantly shorter than those in the control group (P <0.05). The effective rate of the observation group was 93.3%; the effective rate of the control group was 80.0%. The effective rate of the two groups was statistically significant (P <0.05). Conclusion: Azithromycin in children with mycoplasma pneumonia is rapid, efficient and convenient, with good clinical curative effect and few side effects. It is worthy of clinical application.